REMS Zone- FDA approves Exjade to remove excess iron in patients with genetic blood disorder
- FDA approves Botox to treat overactive bladder
- FDA approves Octaplas to treat patients with blood clotting disorders
- FDA permits marketing of first test that can simultaneously identify 11 causes of infectious gastroenteritis
- FDA requiring lower recommended dose for certain sleep drugs containing zolpidem
Sorry, but there aren't any posts in the Blog category yet.
BioTrak Research
Tel:760.448.4820
Fax: 760.603.9535
contactus@biotrak.com
